Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation

28Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A mechanism inducing genetic instability, termed aberrant somatic hypermutation (ASHM), has been described in diffuse large B-cell lymphoma. To further investigate whether ASHM also occurs in primary cutaneous marginal zone B-cell lymphoma (PCMZL), we studied the mutational profile of PAX5, RhoH/TTF, cMYC, and PIM1 in 11 PCMZLs. A total of 17 sequence variants were found in 8 of 11 lymphomas cases (72.7%), and they displayed the molecular features typical for the ASHM. Further, two mutations, one mutation in PIM1 and one in cMYC, led to amino-acid substitution with potential functional consequences. These data indicate that ASHM is associated with PCMZLs. By mutating regulatory and coding sequences of the targeted genes, ASHM may represent a major contributor to their pathogenesis. © 2009 The Society for Investigative Dermatology.

Cite

CITATION STYLE

APA

Deutsch, A. J. A., Frühwirth, M., Aigelsreiter, A., Cerroni, L., & Neumeister, P. (2009). Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation. Journal of Investigative Dermatology, 129(2), 476–479. https://doi.org/10.1038/jid.2008.243

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free